Abstract
PLK1 is a proviral host factor that could be envisaged as a target for combined antiviral and antitumoral strategies against HBV infection and HBV-mediated carcinogenesis. (Hepatology 2017;66:1750-1765).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have